Document:

EX-10.16

EXHIBIT 10.16 

HERITAGE FINANCIAL CORPORATION
DEFERRED COMPENSATION PLAN
PARTICIPATION AGREEMENT

This Participation Agreement (“Participation Agreement”) is effective as of January 1, 2015 (the “Award Date”) by and between HERITAGE FINANCIAL CORPORATION (the “Company”) and Bryan D. McDonald, an employee of the Company (the “Participant”).  Except for terms defined herein, any capitalized term in this Participation Agreement has the meaning ascribed to that term under the Heritage Financial Corporation Deferred Compensation Plan, as amended (the “Plan”).
WHEREAS, the Company has adopted the Plan, effective July 1, 2012, as amended and restated August 29, 2012, and the Committee has determined that the Participant is eligible to receive Company Contributions under the Plan subject to the terms and conditions set forth in the Plan and this Participation Agreement.
WHEREAS, this Participation Agreement is being offered to the Participant in connection with the Participant’s entering into an employment agreement with the Company concurrent herewith, and all rights and obligations set forth herein shall be strictly subject to and contingent upon the Participant entering into such employment agreement contemporaneous herewith.
NOW, THEREFORE, in consideration of the foregoing and the mutual promises and covenants of the parties hereto set forth in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby expressly covenant and agree as follows:
Section 1.Company Contributions.  
(a)For Plan Years 2015 through (and including) 2017, the Company shall make Company Contributions, to be reflected in the Participant’s Company Contribution Account, as determined in accordance with Exhibit A hereto.  The performance metrics and targets in connection with such Company Contributions shall be established each year in the sole discretion of the Committee, following consultation with the Chief Executive Officer of the Company.  In the event Company performance relative to the established performance metrics and targets is impacted by a decision or activity that is outside of the Company’s current annual financial plan, but supports the Company's long-term strategic plan, the Committee shall give consideration to overall corporate results and achievements.  The Committee may exercise discretion regarding the performance metrics used to assess overall corporate performance relative to both the Company’s current annual financial plan and long-term strategic plan when determining Company Contributions.  Decisions and activities that may occur that are outside of the Company’s current annual financial plan may include acquisitions, acquisition-related accounting issues, changes in FDIC premiums, special assessments, gains or losses on bank-owned properties and other events that were not foreseeable at the time the Company’s current annual financial plan was prepared.
(b)Any Company Contributions made pursuant to this Participation Agreement shall be reflected in the Participant’s Company Contribution Account effective as of the January 1 immediately following the Plan Year to which the Company Contribution relates.  
(c)In order to be eligible to receive a Company Contribution for a Plan Year, the Participant must (i) have a performance rating of at least “satisfactory” for the Plan Year to which the Company Contribution relates (as determined by the Committee) and (ii) not have incurred a Separation from Service prior to the end of the Plan Year to which the Company Contribution relates; provided, however, that the 

Participant shall be eligible to receive a pro rata Company Contribution for any Plan Year during which the Participant incurs a Separation from Service due to the Participant’s Disability or death, termination by the Company without Cause or termination by the Participant for Good Reason or following age 65, with such pro rata Company Contribution based upon the number of days in such Plan Year prior to the Participant’s Separation from Service and actual Company performance for the entire Plan Year.
Section 2.Company Contribution Account.  The Participant’s Company Contribution Account shall, in accordance with the Plan, be credited with the Interest Rate as of each Valuation Date until all amounts in such Company Contribution Account have been fully distributed or forfeited.
Section 3.Vesting and Forfeiture of Company Contribution Account
(a)Subject to Section 3(b), Section 3(c) and Section 3(d) below, the portion of the Participant’s Company Contribution Account attributable to this Participation Agreement shall vest in accordance with the following schedule, with no pro rata vesting, provided that the Participant has not incurred a Separation from Service prior to the respective vesting date:
	
		
	Percentage of Company Contribution
	Vesting Date

	0%
	Award Date

	Initial 10%
	January 1, 2016

	Additional 10%
	January 1, 2017

	Additional 10%
	January 1, 2018

	Additional 10%
	January 1, 2019

	Additional 10%
	January 1, 2020

	Additional 10%
	January 1, 2021

	Additional 10%
	January 1, 2022

	Additional 10%
	January 1, 2023

	Additional 10%
	January 1, 2024

	Final 10%
	January 1, 2025

(b)The Participant’s entire Company Contribution Account shall fully vest upon (i) a Change in Control that occurs on or before the Participant’s Separation from Service, (ii) the Participant’s Disability, and (iii) the Participant’s death.
(c)In the event the Participant’s Separation from Service, other than as provided in Section 3(b) above and other than for Cause, occurs prior to the vesting of the Participant’s Company Contribution Account, the Participant shall forfeit all rights, title and interest in and to any unvested amounts in the Participant’s Company Contribution Account as of the Participant’s Separation from Service.
(d)In the event of the Participant’s Separation from Service for Cause, the Participant shall forfeit all rights, title and interest in and to any vested and unvested amounts in the Participant’s Company Contribution Account as of the Participant’s Separation from Service.
Section 4.Distribution of Company Contribution Account
(a)Distribution Events.  
(i)Subject to Section 15(l) of the Plan, distribution of the vested portion of the Participant’s Company Contribution Account shall commence on the fifth day of the month following the later to occur of the Participant’s attainment of age 65 or the Participant’s Separation from Service other than due to the Participant’s Disability or death.
(ii)Notwithstanding Section 4(a)(i) above, in the event of the Participant’s Disability or death, distribution of the vested portion of the Participant’s Company Contribution Account shall commence on the fifth day of the month following such Disability or death.
(b)Form of Distribution.  
(i)Subject to Section 15(l) of the Plan, in the event of distribution of the Participant’s Company Contribution Account due to the Participant’s attainment of age 65 or the Participant’s Separation from Service other than due to the Participant’s Disability or death, such distribution shall be paid 

in 24 equal monthly installments; provided, however, that if such Separation from Service occurs within 24 months following a Change in Control, such distribution shall be in a lump sum.  
(ii)In the event of distribution of the Participant’s Company Contribution Account due to the Participant’s Disability or death, such distribution shall be in a lump sum.
(c)Change in Distribution.  The Participant may elect to change the timing of distribution set forth in this Section 4 to a later date, in accordance with Code Section 409A and such rules and procedures as the Company may prescribe, subject to the following:
(i)Such election may not take effect until at least 12 months after the date it is filed with the Company;
(ii)Such election must be made not later than 12 months prior to the first scheduled payment date; and
(iii)To the extent required under Code Section 409A, the revised payment date must be not sooner than the five-year anniversary of the previously-scheduled payment date.
Section 5.Miscellaneous
(a)Restrictive Covenants.  The Participant shall be bound by the restrictive covenants and other terms and conditions set forth in Exhibit B hereto.  
(b)Tax Withholding.  The Company may withhold any taxes that are required to be withheld from the benefits provided under this Participation Agreement and the Plan.  The Participant acknowledges that the Company’s sole liability regarding taxes is to forward any amounts withheld to the appropriate taxing authorities and to satisfy all applicable reporting requirements.
(c)Plan Governs.  Notwithstanding any provision of this Participation Agreement to the contrary, this Participation Agreement is subject to the terms of the Plan, a copy of which may be obtained by the Participant from the Company.  This Participation Agreement is subject to all interpretations, amendments, rules and regulations promulgated by the Committee from time to time pursuant to the Plan.  Notwithstanding anything in this Participation Agreement to the contrary, in the event of any discrepancy between the corporate records of the Company and this Participation Agreement, the corporate records of the Company shall control.

(signature page follows)

IN WITNESS WHEREOF, each of the parties hereto has caused this Participation Agreement to be executed as of March 9, 2015.

HERITAGE FINANCIAL CORPORATION
By: /s/ BRIAN L. VANCE    Its: Chief Executive Officer
PARTICIPANT
/s/ Bryan D. McDonald
Bryan D. McDonald
Exhibit A
[TO BE UPDATED TO CORRESPOND TO PERFORMANCE METRICS FOR EXECUTIVES FOR 2015]
Company Contribution - 2015 Plan Year
Pursuant to Section 1 of the Participation Agreement, a Company Contribution shall be made for the 2015 Plan Year contingent upon achievement of the applicable “Performance Metrics” set forth in the table immediately below.
If actual [Metric] is below the Minimum for the 2015 Plan Year, the Company Contribution with respect to the [Metric] shall be 0% of the Participant’s Annual Base Salary as in effect on December 31, 2015.  If actual [Metric] is at the Minimum for the 2015 Plan Year, the Company Contribution with respect to the [Metric] shall be 5% of the Participant’s Annual Base Salary as in effect on December 31, 2015.  If actual [Metric] is at or above the Maximum for the 2015 Plan Year, the Company Contribution with respect to the [Metric] shall be 17.5% of the Participant’s Annual Base Salary as in effect on December 31, 2015.  If actual [Metric] is at the Target for the 2015 Plan Year, the Company Contribution with respect to the [Metric] shall be 10% of the Participant’s Annual Base Salary as in effect on December 31, 2015.  If actual [Metric] is between the Minimum and the Target or the Maximum and the Target for the 2015 Plan Year, the Company Contribution shall be determined based upon linear interpolation.  For example, if actual [Metric] is 0.525% for the 2015 Plan Year, the Company Contribution with respect to the [Metric] shall be 7.5% of the Participant’s Annual Base Salary as in effect on December 31, 2015; and if such [Metric] is 0.675%, such Company Contribution shall be 13.75%.
The Company Contribution with respect to the [Metric 2] shall be calculated in the same manner (as described in the immediately preceding paragraph) as the Company Contribution with respect to the [Metric].
2015 Plan Year Performance Criteria and Company Contribution Percentages
	
							
	Performance Metric*
	Weighting
	Minimum*
	Target*
	Maximum*
	Actual Performance Result
	Company Contribution‡

	[Metric]
	50%
	

(5% Company Contribution)
	

(10% Company Contribution)
	

(17.5% Company Contribution)
	$________
	_____%

	[Metric 2]
	50%
	

(5% Company Contribution)
	

(10% Company Contribution)
	

(17.5% Company Contribution)
	_____%
	_____%

	Total 2015 Plan Year Company Contribution
	_____%

*The above Performance Metrics and Minimums, Targets and Maximums shall be established each year in the sole discretion of the Committee, following consultation with the Chief Executive Officer of the Company.
‡As % of Annual Base Salary as of December 31, 2015.

Company Contribution Opportunities (as % of Annual Base Salary)
	
				
	 
	[Metric] (50%)
	[Metric 2] (50%)
	Total Company Contribution (as % of Annual Base Salary†)

	Minimum
	5%
	5%
	10.00%

	Target
	10%
	10%
	20.00%

	Maximum or above
	17.5%
	17.5%
	35.00%

†As in effect on December 31 of the applicable Plan Year.
Exhibit B
Restrictive Covenants
(a)Restrictive Covenants.  The Participant hereby acknowledges and agrees that the non-competition, non-solicitation and other restrictive covenants (the “Restrictive Covenants”) set forth in Section 6 of that certain Employment Agreement made and entered into by and between the Participant and the Company, entered into October 23, 2013 (the “Employment Agreement”), are hereby incorporated into this Participation Agreement by reference as if fully and independently restated herein.  Such Restrictive Covenants shall only be modified for purposes of this Participation Agreement by an amendment of this Participation Agreement by the parties hereto in writing and shall be unaffected by any amendment or termination of the Employment Agreement unless this Participation Agreement is amended independently.
(b)Remedies for Breach of Restrictive Covenants.  The Participant has reviewed the provisions of this Exhibit B with legal counsel, or has been given adequate opportunity to seek such counsel, and the Participant acknowledges and expressly agrees that the covenants contained in this Exhibit B are reasonable with respect to their duration, geographical area and scope.  The Participant further acknowledges that the restrictions contained in this Exhibit B are reasonable and necessary for the protection of the legitimate business interests and confidential information of the Company, that they create no undue hardships, that any violation of these restrictions would cause substantial injury to the Company and such interests, and that such restrictions were a material inducement to the Company to enter into this Participation Agreement.  In the event of any violation or threatened violation of the restrictions contained in this Exhibit B, in addition to and not in limitation of, any other rights, remedies or damages available to the Company under this Participation Agreement or otherwise at law or in equity,
i.The Company shall be entitled to preliminary and permanent injunctive relief to prevent or restrain any such violation by the Participant and any and all persons directly or indirectly acting for or with the Participant, as the case may be; and
ii.The Participant shall forfeit all rights, title and interest in and to any vested and unvested amounts in the Participant’s Company Contribution Account.
(c)Condition Precedent.  Compliance with the Restrictive Covenants shall be a condition precedent to distribution of any amounts from the Participant’s Company Contribution Account.
(d)Similar Restrictive Covenants.  In the event of the existence of any other agreement between the Participant and the Company or an affiliate that (i) is in effect during the restricted periods under the Restrictive Covenants, and (ii) contains restrictive covenants that conflict with any of the provisions of this Exhibit B, then the more restrictive of such provisions from the agreements shall control for the period during which the agreements would otherwise be in effect.ZGNX-2014.12.31-Ex 10.52

 

CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

AMENDMENT NO. 3 - DEVELOPMENT AND OPTION AGREEMENT
THIS AMENDMENT NO. 3 – DEVELOPMENT AND OPTION AGREEMENT (the “Amendment No. 3”) is made as of October 30, 2014 (the “Amendment No. 3 Effective Date”), by and between ALTUS FORMULATION INC., a Quebec company, having its principal place of business at 17800 Rue Lapointe, Mirabel Quebec J7J 1P3, Canada (“Altus”), and ZOGENIX, INC., a Delaware corporation, having its principal place of business at 12400 High Bluff Drive, Suite 650, San Diego, CA  92130 USA (“Zogenix”).  Each of Altus and Zogenix are sometimes referred to herein individually as a “Party” and together as the “Parties”.
WHEREAS, the Parties entered into a Development and Option Agreement dated as of November 1, 2013 (the “Agreement”), regarding their collaboration on the development of certain licensed products; 
WHEREAS, the Parties previously amended the terms of the Agreement pursuant to that certain Amendment No. 1 dated March 10, 2014 (“Amendment No. 1”) and that certain Amendment No. 2 dated September 15, 2014 (“Amendment No. 2”); and
WHEREAS, the Parties wish to amend certain terms of the Agreement pursuant to Section 10.4 thereof, on the terms and subject to the conditions set forth herein.
NOW, THEREFORE, in consideration of the premises and the mutual promises and covenants contained herein, and for good and valuable consideration, the Parties hereby agree as follows:
1.DEFINITIONS. Unless otherwise indicated, capitalized terms used but not defined herein shall have the respective meanings assigned to such terms in the Agreement.
		
	2.
	PURCHASE OF [***]. 

2.1    Payment by Zogenix.  Within three (3) business days of the Amendment No. 3 Effective Date, Zogenix shall make a non-refundable payment to Altus of US$[***] (“[***] Payment”), to be used by Altus solely to purchase [***] with the specifications set forth on Attachment A hereto (the “[***]”), to advance the research and development studies of the Agreement. 
2.2    Credit Against Zogenix Milestone Payment.  The Parties agree that the [***] Payment shall be credited against the US$[***] milestone payment to be made by Zogenix to Altus upon [***] (specifically, [***] of Exhibit C – License Terms of the Agreement) (“[***]”), and that the amount payable upon [***] shall be US$[***].  The Parties confirm that Zogenix previously paid Altus $[***] pursuant to Amendment No. 1 and that such payment was credited against the [***].  For clarification, the Parties confirm that the reduction of the amount payable upon the achievement of the [***] is the sole consideration for the payment contemplated in Section 2.1 above, and that in the event that Zogenix does not exercise the Option or that the [***] is not achieved no other consideration shall be provided and Zogenix shall have no other claim, right or recourse of any nature, including specifically with respect to the [***].
2.3    Ownership.  Nothing in this Amendment No. 3 shall provide Zogenix with any ownership interest or title to the [***], nor any security right or interest with respect thereto.
		
	3.
	CANADIAN RIGHTS

3.1    Negotiation with Paladin.  Altus agrees to use commercially reasonable efforts to negotiate with Paladin Labs, Inc. (“Paladin”) a license under the Altus Know-How and Altus Patents for the Licensed Product in Canada if Daravita Limited (“Daravita”) amends that certain License and Distribution Agreement dated May 12, 2011 between Daravita and Paladin (“Daravita-Paladin Agreement”) to obligate Paladin to use commercially reasonable efforts to negotiate a license with Altus.  For clarity, if either Altus or Paladin fails to agree to use such commercially reasonable efforts, then the other shall have no obligation to do so. 
		
	4.
	MISCELLANEOUS.

4.1    Entire Agreement.  Amendment No, 1, Amendment No. 2, this Amendment No. 3 and the Agreement shall constitute the entire agreement between the parties on the subject matter hereof and shall supersede all other written or oral communication, proposals, drafts, amendments, agreements and representations between the Parties hereto with respect to the subject matter hereof.  
4.2    No Other Changes.  Except as expressly amended herein, all other provisions of the Agreement remain unchanged and in full force and effect.
4.3    Conflict.  In the event of a conflict between the provisions of the Agreement and this Amendment No. 3, the terms of this Amendment No. 3 shall prevail.
4.4    Counterparts.  This Amendment No. 3 may be executed in counterparts, each of which shall be deemed an original document, and all of which, together with this writing, shall be deemed one instrument.  This Amendment No. 3 may be executed by facsimile or PDF signatures, which signatures shall have the same force and effect as original signatures.
 [Signature page follows]

IN WITNESS WHEREOF, the Parties have duly executed this Amendment No. 3 as of the Amendment No. 3 Effective Date.
	
		
	Zogenix, Inc.
	Altus Formulation Inc.

	By:    /s/ Stephen J. Farr                                  
Name: Stephen J. Farr
Title: President
	By:    /s/ Damon Smith                                    
Name: Damon Smith
Title: CEO

Attachment A
[***] 
[***]
[***] 
[***] 
[***] 
[***] 
[***] 

 SD\1565768.1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}]]